Healthcare >> Analyst Interviews >> September 30, 1999
RACHEL LEHENY, PhD, is a Senior Vice President at Lehman Brothers
covering Biotechnology. She was previously associated with Warburg
Dillon Read and Hambrecht & Quist. Prior to that Ms. Leheny was a
National Institutes of Health Fellow and a Lecturer in the Chemistry
Department at the University of California and also worked for Allen &
Company. She received an AB in Chemistry from Harvard College and a PhD
in Chemistry from Columbia University. Profile
sciences. Would it be correct to look at biotechnology almost as the
cornerstone of life sciences?
Ms. Leheny: In some ways
